The presence of additional cytogenetic abnormalities (ACAs) or Philadelphia chromosome variants do not adversely affect the achievement of treatment-free remission in chronic myeloid leukemia

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
JournalAmerican journal of hematology
DOIs
StateAccepted/In press - 2024

ASJC Scopus subject areas

  • Hematology

Cite this